Developing Optimal Formulations Using Biorelevant Predictive Tools And Advanced Bioavailability Enhancement Technologies
Source: Catalent
By Jennifer Dressman, Professor, University of Frankfurt and Fraunhofer Institute of Translational Medicine and Pharmacology, and Stephen Tindal, Director, Science and Technology, Catalent
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Catalent
This website uses cookies to ensure you get the best experience on our website. Learn more